|Articles|July 20, 2023
How Can Phase I Data from the West Accelerate Drug Development in China and Japan? The Science and Practice of Ethnobridging
Author(s)PAREXEL
There is great value in global, multi-ethnic approaches to early-phase drug development, and they can accelerate the availability of new therapies in Asia.
Related Content
Trending on Applied Clinical Trials Online
1
From Study-by-Study to Portfolio Recruitment: Q&A with Gaynor Anders, Trialbee
2
ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN
3
ACT Brief: Sponsor Accountability in Outsourcing, Biomarker Strategy in Precision Oncology, and Novel Sciatica Therapy
4
Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology
5